Medicine and Dentistry
Pancreatic Duct
100%
Surgery
96%
Endoscopic Submucosal Dissection
85%
Endoscopic Retrograde Cholangiopancreatography
80%
Radiofrequency Ablation
62%
Overall Survival
58%
Biliary Tract Drainage
58%
Cholestasis
58%
Analgesia
57%
Chronic Pancreatitis
57%
Liver Biopsy
54%
Esophageal Adenocarcinoma
54%
Esophagus
54%
Gastrointestinal Bleeding
50%
Liver Graft
50%
Sclerosing Cholangitis
50%
Group Trial
50%
Senescence
50%
Pediatrics
50%
Farnesoid X Receptor
50%
Primary Sclerosing Cholangitis
50%
Cetuximab
50%
Kruppel Like Factor 6
50%
Patient with Ulcerative Colitis
50%
Fluorodeoxyglucose F 18
50%
Metastatic Colorectal Cancer
50%
Prospective Study
50%
Disease Course
50%
Diagnostic Performance
50%
Progression Free Survival
50%
Hepatocyte
50%
Polyethylene Terephthalate
50%
Colorectal Carcinoma
50%
Mucosal Cancer
50%
Esophageal Squamous Cell Carcinoma
50%
Intestine Villus Atrophy
50%
Cancer Cell
50%
Adenocarcinoma
50%
Recurrent Fever
50%
Pancytopenia
50%
Colon
50%
Squamous Cell
50%
Eosinophilic Esophagitis
50%
Safety Procedure
50%
Peroral Endoscopic Myotomy
50%
Primary Biliary Cirrhosis
50%
Ursodeoxycholic Acid
50%
Adverse Event
47%
Lymph Node Metastasis
37%
Intention-to-Treat Analysis
34%
Lymphadenitis
33%
Leishmania
33%
Endoscopic Surgery
32%
Primary Tumor
30%
Chromoendoscopy
29%
Magnifying Endoscopy
29%
Extracorporeal Shock Wave Lithotripsy
28%
Liver Transplantation
26%
Lower Gastrointestinal Bleeding
25%
Bleeding
25%
Lymph Duct
25%
Narrow Band Imaging
25%
Neoplasm
24%
Diagnosis
22%
Arm
21%
Clinical Trial
20%
Patient-Reported Outcome
20%
Molecular Profiling
20%
Tumor Invasion
20%
Esophagus Perforation
20%
Intensive Care Unit
18%
Recurrence Risk
18%
Diseases
17%
Carcinoma
17%
Fibrosis
16%
Reaction Analysis
16%
Lugol
16%
Hepatosplenomegaly
16%
Cervical Lymphadenopathy
16%
Agranulocytosis
16%
Amphotericin B
16%
Sore Throat
16%
Macrophage Activation Syndrome
16%
Pathogen and the Immune System
16%
Obeticholic Acid
14%
Clearance
14%
Lithotripsy
14%
Endoscopy
13%
Cholangitis
12%
Clinical Guideline
12%
Symptomatology
12%
Clinical Management
12%
Risk Stratification
12%
Drug Therapy
12%
Endoscopic Mucosal Resection
12%
Ablation Therapy
12%
Squamous Cell Carcinoma
12%
Esophageal Cancer
12%
Alpha Adrenergic Receptor Blocking Agent
12%
Biological Product
12%
Pharmacology, Toxicology and Pharmaceutical Science
Progression Free Survival
62%
Liver Cell Carcinoma
54%
Overall Survival
54%
Farnesoid X Receptor
50%
Atezolizumab
50%
Kruppel Like Factor 6
50%
Cetuximab
50%
Bevacizumab
50%
Primary Sclerosing Cholangitis
50%
Polyethylene Terephthalate
50%
Metastatic Colorectal Cancer
50%
Disease Course
50%
Eosinophilic Esophagitis
50%
Primary Biliary Cirrhosis
50%
Primary Tumor
30%
Clinical Trial
22%
Neoplasm
20%
Obeticholic Acid
14%
Vasculotropin
12%
Survival Rate
12%
Tolerability
12%
Combination Therapy
10%
Adverse Event
10%
Knockout Mouse
8%
Cholestasis
8%
Liver Injury
8%
Alpha Adrenergic Receptor Blocking Agent
7%
Immunomodulating Agent
7%
Azathioprine
7%
Sjoegren Syndrome
7%